Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

NRT Firms’ Deference To “Informal” FDA Letters In Prop 65 Case Improper

Apr 28 2003

• By The Tan Sheet

Related Content

FDA Prop 65 NRT Warning Rejection Should Be Given Deference, Firms Say

Feb 10 2003

Prop 65 Smoking Cessation Warnings Not In Conflict With FDA Rules – Court

Jul 22 2002

Nicotine Replacement Therapy Prop 65 Warning Unfounded, FDA Tells Court

Sep 23 2002

Additional Topics

OTC Drugs Consumer

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window